Prot #000133: Sepsis-ACT: A Double-blind, Randomised, Placebo-controlled, Phase 2b/3 Adaptive Clinical Trial Investigating the Efficacy and Safety of Selepressin as Treatment for Patients with Vasopressor-dependent Septic Shock

Project: Research project

Project Details

StatusFinished
Effective start/end date7/17/17 → 7/17/20

Funding

  • PPD Investigator Services, LLC (Prot #000133)
  • Ferring Pharmaceuticals A/S (Prot #000133)